146 related articles for article (PubMed ID: 26988918)
1. MicroRNA-related polymorphisms in apoptosis pathway genes are predictive of clinical outcome in patients with limited disease small cell lung cancer.
Jiang W; Bi N; Zhang WJ; Wu LH; Liu LP; Men Y; Wang JB; Liang J; Hui ZG; Zhou ZM; Wang LH
Oncotarget; 2016 Apr; 7(16):22632-8. PubMed ID: 26988918
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes.
Jiang W; Zhang W; Wu L; Liu L; Men Y; Wang J; Liang J; Hui Z; Zhou Z; Bi N; Wang L
Biomed Res Int; 2017; 2017():6501385. PubMed ID: 28280736
[TBL] [Abstract][Full Text] [Related]
3. Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.
Qian J; Gu S; Wu Q; Zhao X; Wu W; Gao Z; Zhang W; Tan X; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
Chest; 2012 Sep; 142(3):680-689. PubMed ID: 22441531
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-binding site SNPs in deregulated genes are associated with clinical outcome of non-small cell lung cancer.
Xu J; Tian S; Yin Z; Wu S; Liu L; Qian Y; Pei D; Gao W; Xu J; Yin Y; Liu P; Shu Y
Lung Cancer; 2014 Sep; 85(3):442-8. PubMed ID: 24997136
[TBL] [Abstract][Full Text] [Related]
5. Tumor invasion and metastasis regulated by microRNA-184 and microRNA-574-5p in small-cell lung cancer.
Zhou R; Zhou X; Yin Z; Guo J; Hu T; Jiang S; Liu L; Dong X; Zhang S; Wu G
Oncotarget; 2015 Dec; 6(42):44609-22. PubMed ID: 26587830
[TBL] [Abstract][Full Text] [Related]
6. Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.
Yang Y; Gao W; Ding X; Xu W; Liu D; Su B; Sun Y
Oncotarget; 2017 Mar; 8(10):16313-16324. PubMed ID: 27462918
[TBL] [Abstract][Full Text] [Related]
7. The Relevance of SNPs at 3'UTR Region of CASP7 and miR-371b-5p Associated Diseases: A Computational Analysis.
Safdar M; Zaheer S; Khailany RA; Parvez S; Naveed M; Bhuiyan P; Ozaslan M; Moatasam R; Al-Attar MS; Khan MA; Junejo Y
Cell Biochem Biophys; 2020 Dec; 78(4):541-557. PubMed ID: 32951155
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.
Knoefel LF; Werle-Schneider G; Dally H; Müller PJ; Edler L; Bartsch H; Tuengerthal S; Heussel CP; Reinmuth N; Thomas M; Risch A
J Thorac Oncol; 2011 Jan; 6(1):183-9. PubMed ID: 21107291
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms within MicroRNAs, MicroRNA targets, and MicroRNA biogenesis genes and their impact on colorectal cancer survival.
Mullany LE; Herrick JS; Wolff RK; Slattery ML
Genes Chromosomes Cancer; 2017 Apr; 56(4):285-295. PubMed ID: 27859935
[TBL] [Abstract][Full Text] [Related]
11. Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapy.
Li D; Wei L; Xu B; Yu D; Chang J; Yuan P; Du Z; Tan W; Shen H; Wu T; Wu C; Lin D
PLoS One; 2014; 9(11):e113574. PubMed ID: 25415319
[TBL] [Abstract][Full Text] [Related]
12. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K
Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the caspase genes and the risk of lung cancer.
Lee SY; Choi YY; Choi JE; Kim MJ; Kim JS; Jung DK; Kang HG; Jeon HS; Lee WK; Jin G; Cha SI; Kim CH; Jung TH; Park JY
J Thorac Oncol; 2010 Aug; 5(8):1152-8. PubMed ID: 20661084
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
15. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
Niu N; Schaid DJ; Abo RP; Kalari K; Fridley BL; Feng Q; Jenkins G; Batzler A; Brisbin AG; Cunningham JM; Li L; Sun Z; Yang P; Wang L
BMC Cancer; 2012 Sep; 12():422. PubMed ID: 23006423
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY; Kang HG; Yoo SS; Kang YR; Choi YY; Lee WK; Choi JE; Jeon HS; Shin KM; Oh IJ; Kim KS; Lee J; Cha SI; Kim CH; Kim YC; Park JY
Lung Cancer; 2013 Nov; 82(2):330-9. PubMed ID: 23973201
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
18. A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer.
Hong MJ; Lee SY; Choi JE; Jin CC; Kang HJ; Baek SA; Lee SY; Shin KM; Jeong JY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Son JW; Park JY
Oncotarget; 2016 Mar; 7(13):15948-58. PubMed ID: 26893365
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer.
Ranade AR; Cherba D; Sridhar S; Richardson P; Webb C; Paripati A; Bowles B; Weiss GJ
J Thorac Oncol; 2010 Aug; 5(8):1273-8. PubMed ID: 20548249
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
